Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structured Treatment Interruption: Approaches and Risks.

Mark Dybul1

  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 31/Rm 7A-03, Bethesda, MD 20892, USA. mdybul@nih.gov

Current Infectious Disease Reports
|April 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Africa's ownership of a sustainable health journey towards an AIDS-free future.

BMJ global health·2026
Same author

The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.

Annals of internal medicine·2026
Same author

Integrating HIV services in an era of global change.

Journal of the International AIDS Society·2026
Same author

Navigating health financing cliffs: a new era in global health.

Lancet (London, England)·2025
Same author

Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox now.

PLOS global public health·2024
Same author

Political courage needed to prevent the next pandemic.

Lancet (London, England)·2024

Structured treatment interruptions aim to improve HIV therapy sustainability. However, current strategies are not recommended for standard clinical practice due to various risks and limited evidence.

Area of Science:

  • Infectious Diseases
  • Virology
  • Clinical Medicine

Background:

  • Highly active antiretroviral therapy (HAART) effectively suppresses HIV replication but faces challenges like toxicity, adherence, and cost.
  • These limitations hinder long-term HAART effectiveness and accessibility for many individuals with HIV infection.

Purpose of the Study:

  • To review and summarize various approaches to structured treatment interruptions (STIs) in HIV infection.
  • To evaluate the associated risks and current clinical recommendations for STIs.

Main Methods:

  • Literature review of studies on structured treatment interruptions in HIV-infected patients.
  • Analysis of different STI strategies, patient populations, theoretical frameworks, and clinical trial designs.

Related Experiment Videos

Main Results:

  • Structured treatment interruptions encompass diverse strategies with varied patient groups and designs.
  • The review identifies significant risks associated with these interruption strategies.

Conclusions:

  • Currently, no structured treatment interruption strategy is recommended for routine clinical practice in HIV management.
  • Further research is needed to establish the safety and efficacy of STIs before widespread adoption.